These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 22495360)
21. [The importance of mutational status in prognosis and therapy of GIST]. Comandone A; Boglione A Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775 [TBL] [Abstract][Full Text] [Related]
22. [Correlation between the expression defects of succinate dehydrogenase subunit protein and its gene mutation in succinate dehydrogenase-deficient gastrointestinal stromal tumors]. Zhang YJ; Cheng YH; Zhang ZF; Guo LX; Li LH Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):661-663. PubMed ID: 34078058 [No Abstract] [Full Text] [Related]
23. Mutation of the Liu QY; Kong LF; Xu ZG; Li Z; Xue HZ Biomed Environ Sci; 2020 May; 33(5):369-373. PubMed ID: 32553082 [No Abstract] [Full Text] [Related]
24. KIT Oncogenic Mutations: Biologic Insights, Therapeutic Advances, and Future Directions. Fletcher JA Cancer Res; 2016 Nov; 76(21):6140-6142. PubMed ID: 27803101 [No Abstract] [Full Text] [Related]
25. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767 [TBL] [Abstract][Full Text] [Related]
26. Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. Matyakhina L; Bei TA; McWhinney SR; Pasini B; Cameron S; Gunawan B; Stergiopoulos SG; Boikos S; Muchow M; Dutra A; Pak E; Campo E; Cid MC; Gomez F; Gaillard RC; Assie G; Füzesi L; Baysal BE; Eng C; Carney JA; Stratakis CA J Clin Endocrinol Metab; 2007 Aug; 92(8):2938-43. PubMed ID: 17535989 [TBL] [Abstract][Full Text] [Related]
32. Familial GI Stromal Tumor With Loss of Heterozygosity and Amplification of Mutant KIT. Forde PM; Cochran RL; Boikos SA; Zabransky DJ; Beaver JA; Meyer CF; Thornton KA; Montgomery EA; Lidor AO; Donehower RC; Park BH J Clin Oncol; 2016 Jan; 34(3):e13-6. PubMed ID: 24868028 [No Abstract] [Full Text] [Related]
33. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors. Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309 [TBL] [Abstract][Full Text] [Related]
34. Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor. Gasparotto D; Rossi S; Campagna D; Scavina P; Tiziano FD; Marzotto A; Toffolatti L; Vitelli CE; Amini M; Dei Tos AP; Maestro R J Clin Oncol; 2016 Apr; 34(11):e99-e103. PubMed ID: 25547508 [No Abstract] [Full Text] [Related]
35. Rare, germline mutation of KIT with imatinib-resistant multiple GI stromal tumors and mastocytosis. Speight RA; Nicolle A; Needham SJ; Verrill MW; Bryon J; Panter S J Clin Oncol; 2013 Jun; 31(16):e245-7. PubMed ID: 23610110 [No Abstract] [Full Text] [Related]
36. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours. Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741 [TBL] [Abstract][Full Text] [Related]
37. Familial gastrointestinal stromal tumors, lentigines, and café-au-lait macules associated with germline c-kit mutation treated with imatinib. Gupta D; Chandrashekar L; Larizza L; Colombo EA; Fontana L; Gervasini C; Thappa DM; Rajappa M; Rajendiran KS; Sreenath GS; Kate V Int J Dermatol; 2017 Feb; 56(2):195-201. PubMed ID: 28074523 [TBL] [Abstract][Full Text] [Related]
38. Succinate dehydrogenase-deficient gastrointestinal stromal tumors. Wang YM; Gu ML; Ji F World J Gastroenterol; 2015 Feb; 21(8):2303-14. PubMed ID: 25741136 [TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature. Ito T; Yamamura M; Hirai T; Ishikawa T; Kanda T; Nakai T; Ohkouchi M; Hashikura Y; Isozaki K; Hirota S Int J Clin Exp Pathol; 2014; 7(11):8024-31. PubMed ID: 25550846 [TBL] [Abstract][Full Text] [Related]